Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hirst CS"'
Autor:
Lee MJ; Department of Archaeology, Durham University, Durham, United Kingdom. Electronic address: matthew.j.lee@durham.ac.uk., Siek TJ; Department of Anthropology, McMaster University, Hamilton, Ontario, Canada., Hirst CS
Publikováno v:
International journal of paleopathology [Int J Paleopathol] 2024 Mar; Vol. 44, pp. 51-64. Date of Electronic Publication: 2023 Dec 25.
Autor:
Hirst CS; Division of Cardiology and the CardioVascular Center, Tufts Medical Center, Boston, MA, United States of America; Ascension Saint John Heart and Vascular Institute, Ascension Saint John Hospital, Detroit, MI, United States of America., Thayer KL; Division of Cardiology and the CardioVascular Center, Tufts Medical Center, Boston, MA, United States of America., Harwani N; Tufts University School of Medicine, Boston, MA, United States of America., Kapur NK; Division of Cardiology and the CardioVascular Center, Tufts Medical Center, Boston, MA, United States of America. Electronic address: nkapur@tuftsmedicalcenter.org.
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2022 Jun; Vol. 39, pp. 38-42. Date of Electronic Publication: 2021 Nov 03.
Autor:
Tahir H; Division of Cardiology, University of Tennessee Medical Center, Knoxville, TN, USA., Livesay J; Division of Cardiology, University of Tennessee Medical Center, Knoxville, TN, USA., Baljepally R; Division of Cardiology, University of Tennessee Medical Center, Knoxville, TN, USA.; Heart Lung Vascular Institute, University of Tennessee Medical Center, Knoxville, TN, USA., Hirst CS; Division of Cardiology, University of Tennessee Medical Center, Knoxville, TN, USA.; Heart Lung Vascular Institute, University of Tennessee Medical Center, Knoxville, TN, USA.
Publikováno v:
Journal of medical cases [J Med Cases] 2021 Jul; Vol. 12 (7), pp. 271-274. Date of Electronic Publication: 2021 May 13.
Autor:
Kapur NK; The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA., Hirst CS; The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA., Davila CD; The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA., Garcia R; The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA.
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2021 Apr 01; Vol. 97 (5), pp. E673-E675. Date of Electronic Publication: 2020 Jun 25.
Autor:
Davila CD; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Esposito M; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Hirst CS; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Morine K; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Jorde L; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Newman S; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Paruchuri V; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Whitehead E; Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States., Thayer KL; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States., Kapur NK; The Cardiovascular Center at Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2021 Feb 11; Vol. 8, pp. 563853. Date of Electronic Publication: 2021 Feb 11 (Print Publication: 2021).
Autor:
Hirst CS; CardioVascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, United States of America., Davila CD; CardioVascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, United States of America., Garcia R; CardioVascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, United States of America., Kapur NK; CardioVascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, United States of America. Electronic address: nkapur@tuftsmedicalcenter.org.
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2020 Nov; Vol. 21 (11S), pp. 112-115. Date of Electronic Publication: 2020 Feb 19.
Autor:
Gris-Oliver A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Palafox M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Monserrat L; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer, Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Òdena A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ibrahim YH; Weil Cornell Medicine, New York, New York., Villacampa G; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Parés M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Bruna A; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge., Hirst CS; Early Oncology, AstraZeneca, Cambridge, United Kingdom., Barnicle A; Early Oncology, AstraZeneca, Cambridge, United Kingdom., de Bruin EC; Early Oncology, AstraZeneca, Cambridge, United Kingdom., Reddy A; Early Oncology, AstraZeneca, Cambridge, United Kingdom., Schiavon G; Early Oncology, AstraZeneca, Cambridge, United Kingdom., Arribas J; Growth Factors Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Mills GB; Department of Cell Development and Cancer Biology, Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Caldas C; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer, Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain., Nuciforo P; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Razavi P; Department of Medicine and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Scaltriti M; Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Turner NC; Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London, United Kingdom., Saura C; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Davies BR; Early Oncology, AstraZeneca, Cambridge, United Kingdom., Oliveira M; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 15; Vol. 26 (14), pp. 3720-3731. Date of Electronic Publication: 2020 Mar 27.
Autor:
Hirst CS; Anthropology Department, University College London, London, UK. cara.hirst.13@ucl.ac.uk.; University College London, Institute of Archaeology, London, UK. cara.hirst.13@ucl.ac.uk., White S; Anthropology Department, University College London, London, UK., Siek T; University College London, Institute of Archaeology, London, UK., Gasparik A; University College London, Institute of Archaeology, London, UK.
Publikováno v:
Surgical and radiologic anatomy : SRA [Surg Radiol Anat] 2020 Jan; Vol. 42 (1), pp. 91-94. Date of Electronic Publication: 2019 Oct 31.
Autor:
Eyre TA; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Hildyard C; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Hamblin A; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Ali AS; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Houlton A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Hopkins L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Royston D; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK., Linton KM; Department of Medical Oncology, The Christie Hospital NHS Trust, Manchester, UK., Pettitt A; Department of Haematology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK., Rule S; Department of Haematology, University of Plymouth Medical School, Plymouth, UK., Cwynarski K; Department of Haematology, University College London, London, UK., Barrington SF; Clinical PET Centre, St Thomas' Hospital, London, UK., Warbey V; Clinical PET Centre, St Thomas' Hospital, London, UK., Wrench D; Department of Haematology, Guy's and St Thomas' Hospital, London, UK., Barrans S; Haematological Malignancy Diagnostic Service, St James' University Hospital, Leeds, UK., Hirst CS; Translational Medicine, AstraZeneca Oncology R&D I Research and Early Development, Cambridge, UK., Panchal A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Roudier MP; Translational Medicine, AstraZeneca Oncology R&D I Research and Early Development, Cambridge, UK., Harrington EA; Translational Medicine, AstraZeneca Oncology R&D I Research and Early Development, Cambridge, UK., Davies A; Cancer Research UK Centre, Cancer Sciences Unit, University of Southampton, Southampton General Hospital, Southampton, UK., Collins GP; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
Publikováno v:
Hematological oncology [Hematol Oncol] 2019 Oct; Vol. 37 (4), pp. 352-359. Date of Electronic Publication: 2019 Sep 09.
Autor:
Nikolopoulou E; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom., Hirst CS; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom.; Horizon Discovery, 8100 Cambridge Research Park, Cambridge, CB25 9TL, United Kingdom., Galea G; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom., Venturini C; UCL Infection and Immunity Division, UCL Pathogen Genomic Unit, UCL Cruciform Building, Gower Street, London, WC1E 6BT, United Kingdom., Moulding D; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom., Marshall AR; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom., Rolo A; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom.; Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal., De Castro SCP; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom., Copp AJ; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom., Greene NDE; Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, United Kingdom. n.greene@ucl.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2019 Jun 06; Vol. 10 (1), pp. 2487. Date of Electronic Publication: 2019 Jun 06.